Selin Cebeci

5PUBLICATIONS
43CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 06, 2026
Immune-Mediated upper gastrointestinal toxicities reported With immune checkpoint inhibitors: An analysis of the food and drug administration adverse event reporting system (FAERS).

|May 04, 2026
Oligoprogression During First-Line Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Comparative Outcomes of Metastasis-Directed Radiotherapy and Systemic Treatment Change.

|Mar 28, 2026
Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Vali Aliyev, Ali Kaan Güren, Murad Guliyev

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG).

Sercan On, Selin Cebeci, Zeynep Hande Turna

|Dec 30, 2025
Stage II colon cancer: does ChatGPT recommend more intensive adjuvant therapy? A comparison with MDT decisions.

Zeliha Birsin, Seda Jeral, Selin Cebeci

Pageof 1

Frequent Collaborators

4 joint publications

Zeliha Birsin

4 joint publications

Hamza Abbasov

4 joint publications

Özkan Alan

3 joint publications

Seda Jeral